Morgan Stanley Downgrades Shockwave Medical to Equal-Weight, Raises Price Target to $335
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood downgraded Shockwave Medical (SWAV) from Overweight to Equal-Weight but raised the price target from $285 to $335.

April 08, 2024 | 11:08 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Shockwave Medical was downgraded by Morgan Stanley from Overweight to Equal-Weight, although the price target was increased from $285 to $335.
The downgrade to Equal-Weight suggests a neutral outlook on the stock's performance, indicating that the stock might perform in line with the market or sector. However, the increase in the price target to $335 from $285 signals a positive view on the company's valuation and future prospects. This mixed signal could lead to short-term uncertainty among investors, balancing out potential impacts on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100